Reti patent opposition analysis

The comprehensive analysis of Reti opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Reti

Patent NumberTitleApplicantOpposition DateOpposition Company
Activated Blood Coagulation Factor X (Fxa) InhibitorDAIICHI SANKYOMay 2, 2017HEXAL

Top companies who are the clients of Reti

CompanyTotal
HEXAL1